Nu Skin Enterprises Inc

Market Summary

USD17.53+0.34

Market Closed

1.98%

NUS Alerts

1 major insider sales recently.
Big fall in earnings (Y/Y)
Losses in recent quarter

NUS Stock Price

View Fullscreen

NUS RSI Chart

NUS Alerts

1 major insider sales recently.
Big fall in earnings (Y/Y)
Losses in recent quarter

NUS Valuation

Market Cap

875.3M

Price/Earnings (Trailing)

14.96

Price/Sales (Trailing)

0.44

EV/EBITDA

5.71

Price/Free Cashflow

22.97

NUS Price/Sales (Trailing)

NUS Profitability

EBT Margin

2.51%

Return on Equity

8.67%

Return on Assets

4.24%

Free Cashflow Yield

4.35%

NUS Fundamentals

NUS Revenue

Revenue (TTM)

2.0B

Revenue Y/Y

-7.26%

Revenue Q/Q

-0.3%

NUS Earnings

Earnings (TTM)

58.5M

Earnings Y/Y

-45.55%

Earnings Q/Q

-237.42%

Price Action

Last 7 days

4.7%

Last 30 days

1.0%

Last 90 days

-23.6%

Trailing 12 Months

-57.6%

How does NUS drawdown profile look like?

NUS Financial Health

Current Ratio

2.08

NUS Investor Care

Buy Backs (1Y)

0.87%

Diluted EPS (TTM)

1.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	2.1B	2.0B	2.0B	0
2022	2.6B	2.5B	2.4B	2.2B
2021	2.7B	2.8B	2.8B	2.7B
2020	2.3B	2.3B	2.4B	2.6B
2019	2.7B	2.6B	2.5B	2.4B
2018	2.4B	2.6B	2.7B	2.7B
2017	2.2B	2.2B	2.1B	2.3B
2016	2.2B	2.2B	2.2B	2.2B
2015	2.4B	2.4B	2.3B	2.2B
2014	3.3B	3.3B	3.0B	2.6B
2013	2.2B	2.3B	2.7B	3.2B
2012	1.8B	2.0B	2.0B	2.1B
2011	1.6B	1.6B	1.6B	1.7B
2010	1.4B	1.4B	1.5B	1.5B
2009	1.3B	1.3B	1.3B	1.3B
2008	0	0	0	1.2B

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for NUS

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 27, 2023	lipman andrew d	sold	-34,220	17.11	-2,000	-
Nov 03, 2023	lipman andrew d	sold	-272,272	17.68	-15,400	-
Oct 25, 2023	lipman andrew d	sold	-38,460	19.23	-2,000	-
Sep 25, 2023	lipman andrew d	sold	-46,040	23.02	-2,000	-
Sep 06, 2023	woodbury edwina d	acquired	626	23.21	27.00	-
Aug 25, 2023	lipman andrew d	sold	-46,660	23.33	-2,000	-
Aug 21, 2023	nathanson laura	sold	-146,360	24.12	-6,068	-
Aug 07, 2023	battle emma s.	sold	-33,262	26.15	-1,272	-
Aug 01, 2023	clark chayce david	sold (taxes)	-6,126	29.74	-206	evp and general counsel
Jul 26, 2023	thomas james d	acquired	-	-	8,328	chief financial officer

Which funds bought or sold NUS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Nov 24, 2023	EP Wealth Advisors, LLC	reduced	-86.37	-122,010	215,833	-%
Nov 24, 2023	DEUTSCHE BANK AG\	added	14.87	-179,585	495,105	-%
Nov 22, 2023	Public Sector Pension Investment Board	reduced	-30.29	-1,631,260	1,309,700	0.01%
Nov 22, 2023	KBC Group NV	unchanged	-	-	133,000	-%
Nov 21, 2023	COMERICA BANK	new	-	507,831	507,831	-%
Nov 21, 2023	Walleye Capital LLC	added	70.33	51,330	633,691	-%
Nov 16, 2023	Creative Planning	new	-	406,024	406,024	-%
Nov 15, 2023	JANE STREET GROUP, LLC	added	108	307,619	1,230,410	-%
Nov 15, 2023	PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	added	14.51	-19,000	52,000	-%
Nov 15, 2023	GSA CAPITAL PARTNERS LLP	sold off	-100	-679,000	-	-%

Latest Funds Activity

Are funds buying NUS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NUS

No. of Funds

Schedule 13G FIlings of Nu Skin Enterprises Inc

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Aug 09, 2023	state street corp	6.11%	3,051,276	SC 13G/A
Feb 13, 2023	renaissance technologies llc	4.63%	2,287,596	SC 13G/A
Feb 09, 2023	vanguard group inc	13.13%	6,490,840	SC 13G/A
Feb 09, 2023	state street corp	14.94%	7,384,649	SC 13G/A
Feb 06, 2023	wellington management group llp	7.15%	3,535,969	SC 13G/A
Jan 23, 2023	blackrock inc.	17.0%	8,414,765	SC 13G/A
May 10, 2022	state street corp	17.66%	8,851,823	SC 13G/A
Feb 11, 2022	renaissance technologies llc	5.24%	2,612,396	SC 13G/A
Feb 10, 2022	state street corp	12.61%	6,280,258	SC 13G
Feb 04, 2022	wellington management group llp	8.35%	4,162,517	SC 13G/A

Recent SEC filings of Nu Skin Enterprises Inc

View All Filings

Date Filed	Form Type	Document
Dec 06, 2023	4	Insider Trading
Nov 28, 2023	4	Insider Trading
Nov 06, 2023	4	Insider Trading
Nov 03, 2023	144	Notice of Insider Sale Intent
Nov 02, 2023	10-Q	Quarterly Report
Nov 01, 2023	8-K	Current Report
Oct 26, 2023	4	Insider Trading
Sep 25, 2023	4	Insider Trading
Sep 25, 2023	144	Notice of Insider Sale Intent
Sep 07, 2023	4	Insider Trading

NUS Fair Value

Peers (Alternatives to Nu Skin Enterprises Inc)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	357.9B	83.3B	-2.82%	-1.73%	25.07	4.46	3.48%	4.57%
CL	63.2B	19.1B	3.03%	0.36%	35.42	3.52	7.86%	-17.69%
EL	50.2B	15.5B	18.36%	-43.74%	49.67	3.15	-10.29%	-58.06%
CHD	22.9B	-	7.67%	16.29%	52.42	75.72	-94.06%	-40.65%
CLX	17.7B	7.0B	10.49%	-3.01%	205.51	2.51	-0.09%	-78.77%
MID-CAP
COTY	10.3B	5.8B	17.36%	45.41%	26.93	1.77	9.07%	135.16%
ELF	6.9B	765.7M	23.42%	128.95%	56.37	8.95	70.85%	258.18%
IPAR	4.2B	1.3B	2.93%	33.82%	26.53	3.24	31.74%	54.03%
NWL	3.4B	8.3B	16.90%	-33.44%	-6.19	0.41	-16.40%	-201.29%
HELE	2.6B	2.0B	9.68%	12.08%	19.05	1.31	-10.15%	-19.20%
SMALL-CAP
HIMS	1.9B	792.6M	41.40%	34.14%	-51.85	2.34	78.34%	58.46%
EPC	1.7B	2.3B	-4.73%	-17.19%	15.15	0.76	3.68%	14.91%
ACU	144.7M	193.7M	21.41%	64.91%	24.17	0.75	-1.01%	0.37%
GROV	66.8M	273.5M	16.07%	-	-1.44	0.24	-18.31%	56.62%
UG	36.4M	11.0M	7.03%	-31.07%	14.42	3.3	-18.80%	-16.08%

Nu Skin Enterprises Inc News

Latest updates

MarketWatch • 05 Dec 2023 • 09:33 pm • 37 hours ago

Tupperware Brands Corp. stock falls Tuesday, underperforms market

Defense World • 05 Dec 2023 • 08:46 am • 2 days ago

Nu Skin Enterprises, Inc. (NYSE:NUS) Given Consensus Rating of ...

Defense World • 01 Dec 2023 • 10:19 am • 6 days ago

BNP Paribas Arbitrage SNC Reduces Holdings in Nu Skin ...

Marketscreener.com • 29 Nov 2023 • 09:16 pm • 7 days ago

Nu Skin Opens New Manufacturing Facility in China

GuruFocus.com • 27 Nov 2023 • 03:05 pm • 9 days ago

What's Driving Hims & Hers Health Inc's Surprising 20% Stock Rally?

GuruFocus.com • 22 Nov 2023 • 08:00 am • 15 days ago

What's Driving Hims & Hers Health Inc's Surprising 16% Stock Rally?

Yahoo Finance • 17 Nov 2023 • 08:00 am • 20 days ago

Here's Why We're Wary Of Buying Nu Skin Enterprises' (NYSE:NUS ...

Yahoo Finance • 06 Nov 2023 • 08:00 am • 31 days ago

Insider Sell: Director Andrew Lipman Sells 15,400 Shares of Nu Skin ...

MarketWatch • 06 Nov 2023 • 08:00 am • 31 days ago

Tupperware Brands Corp. stock outperforms competitors on strong trading day

Yahoo Finance • 02 Nov 2023 • 07:00 am • 35 days ago

Nu Skin Enterprises, Inc. (NYSE:NUS) Q3 2023 Earnings Call ...

Yahoo Finance • 30 Oct 2023 • 07:00 am • 38 days ago

Is Nu Skin Enterprises, Inc.'s (NYSE:NUS) Stock On A Downtrend As ...

Nasdaq • 30 Oct 2023 • 07:00 am • 38 days ago

e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?

Simply Wall St • 28 Oct 2023 • 07:00 am • 40 days ago

Nu Skin Enterprises (NYSE:NUS) stock falls 5.3% in past week as five-year earnings and shareholder returns continue downward trend

Seeking Alpha • 17 Oct 2023 • 07:00 am • 51 days ago

Nu Skin: Is It Just A Growth Problem? (NYSE:NUS)

Yahoo Finance • 10 Oct 2023 • 07:00 am • 58 days ago

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

Financials for Nu Skin Enterprises Inc

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	-0.3%	499	500	481	522	538	561	605	673	641	704	677	748	703	612	518	583	590	624	624	683	675
Gross Profit	-19.9%	292	365	348	375	364	413	443	500	482	532	506	553	520	458	392	443	450	469	477	521	518
Operating Expenses	-1.1%	319	322	332	347	385	361	391	479	417	447	444	465	446	400	356	388	380	395	408	503	437
S&GA Expenses	1.4%	188	185	188	201	216	219	243	263	260	281	276	295	281	249	206	228	232	246	250	269	272
EBITDA Margin	-	-	-	0.06*	0.07*	0.07*	5.02*	0.11*	0.11*	0.14*	0.14*	0.14*	0.14*	0.13*	0.13*	0.14*	0.15*	-	-	-	-	-
Income Taxes	-75.5%	3.00	10.00	3.00	-32.86	-3.57	9.00	12.00	28.00	18.00	22.00	17.00	18.00	18.00	18.00	11.00	13.00	21.00	25.00	23.00	32.00	21.00
Earnings Before Taxes	-192.8%	-34.45	37.00	15.00	24.00	-28.96	43.00	51.00	18.00	68.00	81.00	64.00	91.00	75.00	60.00	30.00	54.00	65.00	71.00	66.00	14.00	74.00
EBT Margin	-	-	-	0.03*	0.04*	0.03*	3.56*	0.08*	0.09*	0.11*	0.11*	0.11*	0.10*	0.09*	0.09*	0.09*	0.11*	-	-	-	-	-
Net Income	-237.4%	-36.95	27.00	11.00	57.00	-25.39	34.00	39.00	-9.23	50.00	59.00	47.00	73.00	56.00	42.00	20.00	40.00	44.00	46.00	43.00	-17.76	53.00
Net Income Margin	-	-	-	0.04*	0.05*	0.02*	2.24*	0.05*	0.05*	0.08*	0.08*	0.08*	0.07*	0.07*	0.06*	0.06*	0.07*	-	-	-	-	-
Free Cashflow	-	-	-	-33.56	12.00	3.00	37.00	-2.74	91.00	17.00	3.00	-38.23	80.00	98.00	88.00	50.00	37.00	-	-	-	-	-

Balance Sheet
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-5.3%	1,793	1,894	1,825	1,821	1,763	1,901	1,892	1,906	1,974	2,050	1,950	1,957	1,817	1,794	1,746	1,769	1,737	1,791	1,755	1,694	1,746
Current Assets	-11.5%	701	793	774	760	778	883	849	873	891	962	901	903	772	786	730	740	739	788	748	799	826
Cash Equivalents	-1.0%	233	236	230	265	294	364	302	340	282	355	339	403	367	376	353	336	320	361	310	387	390
Inventory	-21.8%	291	372	367	346	327	354	382	400	415	391	363	314	270	262	257	276	283	293	304	296	289
Net PPE	-0.3%	429	430	438	445	433	443	449	454	464	474	464	468	456	445	449	454	448	443	446	465	497
Goodwill	0%	229	229	206	206	206	206	206	206	216	216	203	203	197	197	197	197	197	197	197	197	187
Liabilities	-2.8%	971	998	932	924	921	960	958	994	1,038	1,132	1,079	1,063	989	1,002	946	894	891	956	944	913	914
Current Liabilities	-2.5%	434	445	373	359	366	384	494	530	541	616	562	543	466	485	420	357	368	415	402	440	428
LT Debt, Current	0%	140	140	48.00	25.00	43.00	40.00	110	108	110	153	90.00	30.00	30.00	95.00	95.00	28.00	25.00	60.00	45.00	69.00	82.00
LT Debt, Non Current	-1.3%	363	368	373	377	382	387	259	269	279	288	298	305	313	320	327	334	342	349	356	361	366
Shareholder's Equity	-8.2%	822	895	893	897	842	941	934	913	936	918	871	894	827	792	800	875	846	835	811	782	832
Retained Earnings	-2.9%	1,882	1,939	1,931	1,939	1,901	1,946	1,931	1,912	1,940	1,909	1,869	1,841	1,786	1,749	1,727	1,728	1,708	1,685	1,659	1,636	1,675
Additional Paid-In Capital	0.6%	619	616	611	613	610	606	599	602	591	587	579	580	570	563	558	558	557	556	553	553	545
Shares Outstanding	-100.0%	-	50.00	50.00	-	50.00	50.00	50.00	-	50.00	50.00	51.00	-	51.00	52.00	55.00	-	56.00	56.00	55.00	-	56.00

Cashflow (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	43.6%	51,027	35,522	-22,077	25,525	28,441	46,555	7,541	109,509	30,214	20,715	-18,856	94,693	118,367	97,054	69,027	49,903	53,551	82,663	-8,186	88,888	61,917
Share Based Compensation	-22.4%	3,725	4,801	4,002	3,047	3,171	2,022	4,127	6,718	3,093	6,580	6,803	8,621	7,115	4,869	3,455	260	1,015	3,593	5,041	6,298	7,044
Cashflow From Investing	87.1%	-11,906	-92,501	-14,696	-13,385	-25,211	-18,350	-10,133	-15,577	-17,914	-36,439	-18,796	-29,489	-21,450	-9,305	-19,184	-13,283	-23,683	-16,304	-18,142	-33,523	-16,990
Cashflow From Financing	-156.4%	-38,374	67,989	1,380	-50,794	-61,109	46,158	-33,759	-35,916	-80,019	29,388	-18,155	-41,839	-110,794	-69,554	-22,979	-25,552	-62,570	-13,705	-52,967	-57,904	-49,825
Dividend Payments	0.1%	19,486	19,475	19,392	19,027	19,303	19,392	19,293	18,936	19,007	19,040	19,289	19,100	19,245	19,356	20,686	20,553	20,552	20,553	20,531	20,186	20,304
Buy Backs	-	13,011	-	-	10,007	40,028	10,004	10,006	10,005	10,005	10,004	50,406	16,973	19,994	46,481	60,886	-	-	-	825	21,343	12,399

NUS Income Statement

2023-06-30

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Consolidated Statements of Income [Abstract]
Revenue	$ 500,257	$ 560,615	$ 981,719	$ 1,165,514
Cost of sales	135,542	148,100	269,130	309,599
Gross profit	364,715	412,515	712,589	855,915
Operating expenses:
Selling expenses	185,165	219,426	373,289	462,125
General and administrative expenses	137,044	141,562	270,943	290,118
Restructuring and impairment expenses	0	0	9,787	0
Total operating expenses	322,209	360,988	654,019	752,243
Operating income	42,506	51,527	58,570	103,672
Other expense, net	(5,393)	(8,640)	(6,869)	(10,093)
Income before provision for income taxes	37,113	42,887	51,701	93,579
Provision for income taxes	10,221	8,650	13,433	20,626
Net income	$ 26,892	$ 34,237	$ 38,268	$ 72,953
Net income per share (Note 6):
Basic (in dollars per share)	$ 0.54	$ 0.68	$ 0.77	$ 1.45
Diluted (in dollars per share)	$ 0.54	$ 0.67	$ 0.76	$ 1.43
Weighted-average common shares outstanding:
Basic (in shares)	49,931	50,368	49,789	50,181
Diluted (in shares)	50,161	50,960	50,098	50,959

NUS Balance Sheet

2023-06-30

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 235,554	$ 264,725
Current investments	16,772	13,784
Accounts receivable, net	67,166	47,360
Inventories, net	372,250	346,183
Prepaid expenses and other	100,833	87,816
Total current assets	792,575	759,868
Property and equipment, net	430,328	444,806
Operating lease right-of-use assets	94,707	98,734
Goodwill	229,469	206,432
Other intangible assets, net	112,619	66,701
Other assets	234,078	244,429
Total assets	1,893,776	1,820,970
Current liabilities:
Accounts payable	49,529	53,963
Accrued expenses	255,510	280,280
Current portion of long-term debt	140,000	25,000
Total current liabilities	445,039	359,243
Operating lease liabilities	74,487	76,540
Long-term debt	367,753	377,466
Other liabilities	111,152	110,425
Total liabilities	998,431	923,674
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	615,579	613,278
Treasury stock, at cost - 40.6 million and 41.1 million shares	(1,557,777)	(1,569,061)
Accumulated other comprehensive loss	(101,446)	(86,509)
Retained earnings	1,938,898	1,939,497
Total stockholders' equity	895,345	897,296
Total liabilities and stockholders' equity	$ 1,893,776	$ 1,820,970

About Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

CEO	Mr. Ryan S. Napierski
WEBSITE	www.nuskin.com
EMPLOYEES	3800

Nu Skin Enterprises Inc Frequently Asked Questions

What is the ticker symbol for Nu Skin Enterprises Inc? What does NUS stand for in stocks?

NUS is the stock ticker symbol of Nu Skin Enterprises Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nu Skin Enterprises Inc (NUS)?

As of Wed Dec 06 2023, market cap of Nu Skin Enterprises Inc is 875.29 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NUS stock?

You can check NUS's fair value in chart. The fair value of Nu Skin Enterprises Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nu Skin Enterprises Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NUS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nu Skin Enterprises Inc a good stock to buy?

The fair value guage provides a quick view whether NUS is over valued or under valued. Whether Nu Skin Enterprises Inc is cheap or expensive depends on the assumptions which impact Nu Skin Enterprises Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUS.

What is Nu Skin Enterprises Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 06 2023, NUS's PE ratio (Price to Earnings) is 14.96 and Price to Sales (PS) ratio is 0.44. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Nu Skin Enterprises Inc's stock?

In the past 10 years, Nu Skin Enterprises Inc has provided -0.16 (multiply by 100 for percentage) rate of return.

Market Summary

NUS Alerts

NUS Stock Price

NUS RSI Chart

NUS Alerts

NUS Valuation

NUS Price/Sales (Trailing)

NUS Profitability

NUS Fundamentals

NUS Revenue

NUS Earnings

Price Action

How does NUS drawdown profile look like?

NUS Financial Health

NUS Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for NUS

Which funds bought or sold NUS recently?

Latest Funds Activity

Schedule 13G FIlings of Nu Skin Enterprises Inc

Recent SEC filings of Nu Skin Enterprises Inc

NUS Fair Value

Peers (Alternatives to Nu Skin Enterprises Inc)

Nu Skin Enterprises Inc News

Financials for Nu Skin Enterprises Inc

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

NUS Income Statement

NUS Balance Sheet

About Nu Skin Enterprises Inc

Nu Skin Enterprises Inc Frequently Asked Questions

What is the ticker symbol for Nu Skin Enterprises Inc? What does NUS stand for in stocks?

What is the market capital of Nu Skin Enterprises Inc (NUS)?

What is the fair value of NUS stock?

Is Nu Skin Enterprises Inc a good stock to buy?

What is Nu Skin Enterprises Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

What is 5 year return on Nu Skin Enterprises Inc's stock?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)